Scholarly Index
Daniel Birnbaum
Centre National de la Recherche Scientifique; 50,218 total citations; 734 total publications; best world rank #31
Centre National de la Recherche Scientifique
50,218Total citations
734Total publications
116H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Fibroblast Growth Factor Research | Lifetime | 31 | FR 2 | 99.08 |
| Cancer Cells and Metastasis | Lifetime | 157 | FR 4 | 99.17 |
| Cancer Genomics and Diagnostics | Lifetime | 486 | FR 25 | 99.08 |
| Cancer-related Molecular Pathways | Lifetime | 605 | FR 19 | 97.96 |
| HER2/EGFR in Cancer Research | Lifetime | 436 | FR 19 | 98.16 |
| Breast Cancer Treatment Studies | Lifetime | 600 | FR 30 | 98.21 |
| Gene expression and cancer classification | Lifetime | 329 | FR 5 | 96.98 |
| Acute Myeloid Leukemia Research | Lifetime | 936 | FR 67 | 97.57 |
| Kruppel-like factors research | Lifetime | 193 | FR 5 | 95.91 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 402 | FR 26 | 97.13 |
| Genomic variations and chromosomal abnormalities | Lifetime | 546 | FR 28 | 96.59 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 491 | FR 15 | 96.37 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 869 | FR 48 | 96.46 |
| Eosinophilic Disorders and Syndromes | Lifetime | 819 | FR 69 | 94.68 |
| Chromatin Remodeling and Cancer | Lifetime | 628 | FR 38 | 87.39 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 873 | FR 26 | 87.68 |
| FOXO transcription factor regulation | Lifetime | 927 | FR 29 | 74.10 |